SYNCOM FORMULATIONS (INDIA)
Back to Income Statement
|
SYNCOM FORMULATIONS (INDIA) Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2017 | Mar2016 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹25 Cr | ₹20 Cr | ₹20 Cr | ₹11 Cr | ₹10 Cr |
What is the latest Consolidated Net Profit of SYNCOM FORMULATIONS (INDIA) ?
Year | Consolidated Net Profit |
---|---|
Mar2024 | ₹25 Cr |
Mar2023 | ₹20 Cr |
Mar2022 | ₹20 Cr |
Mar2017 | ₹11 Cr |
Mar2016 | ₹10 Cr |
How is Consolidated Net Profit of SYNCOM FORMULATIONS (INDIA) Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2024 | ₹25 Cr | 26.12 | |
Mar2023 | ₹20 Cr | 1.42 | |
Mar2022 | ₹20 Cr | 87.87 | |
Mar2017 | ₹11 Cr | 1.72 | |
Mar2016 | ₹10 Cr | - |
Compare Consolidated Net Profit of peers of SYNCOM FORMULATIONS (INDIA)
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SYNCOM FORMULATIONS (INDIA) | ₹2,003.1 Cr | -3.3% | 21.7% | 73.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹404,420.0 Cr | -0.2% | -2.9% | 12.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹177,572.0 Cr | 0.3% | 6.5% | 49% | Stock Analytics | |
CIPLA | ₹123,329.0 Cr | 1.1% | 1.8% | -1.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹112,396.0 Cr | -0.2% | 9.5% | 12.8% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹110,956.0 Cr | 1.9% | 0.4% | 14% | Stock Analytics |
SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SYNCOM FORMULATIONS (INDIA) | -3.3% |
21.7% |
73.7% |
SENSEX | -0.8% |
-0.9% |
6.9% |
You may also like the below Video Courses